X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18590) 18590
Newsletter (244) 244
Newspaper Article (59) 59
Book Chapter (57) 57
Dissertation (23) 23
Magazine Article (13) 13
Conference Proceeding (8) 8
Government Document (5) 5
Book / eBook (4) 4
Publication (2) 2
Transcript (2) 2
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14992) 14992
science & technology (13739) 13739
life sciences & biomedicine (12792) 12792
paclitaxel - administration & dosage (12488) 12488
female (11013) 11013
paclitaxel (8294) 8294
oncology (7817) 7817
middle aged (7645) 7645
aged (6691) 6691
antineoplastic combined chemotherapy protocols - therapeutic use (6506) 6506
male (6120) 6120
adult (5284) 5284
chemotherapy (4306) 4306
treatment outcome (4136) 4136
cancer (3944) 3944
animals (3498) 3498
paclitaxel - adverse effects (3153) 3153
carboplatin - administration & dosage (3028) 3028
antineoplastic agents, phytogenic - administration & dosage (2849) 2849
paclitaxel - therapeutic use (2750) 2750
breast neoplasms - drug therapy (2665) 2665
antineoplastic combined chemotherapy protocols - adverse effects (2522) 2522
pharmacology & pharmacy (2488) 2488
drug administration schedule (2377) 2377
cisplatin - administration & dosage (2358) 2358
lung neoplasms - drug therapy (2151) 2151
mice (2125) 2125
paclitaxel - pharmacology (2102) 2102
ovarian neoplasms - drug therapy (2080) 2080
cell line, tumor (1999) 1999
neoplasm staging (1997) 1997
breast cancer (1930) 1930
care and treatment (1902) 1902
aged, 80 and over (1714) 1714
research (1658) 1658
antineoplastic combined chemotherapy protocols - administration & dosage (1635) 1635
carcinoma, non-small-cell lung - drug therapy (1633) 1633
disease-free survival (1627) 1627
breast neoplasms - pathology (1525) 1525
ovarian cancer (1493) 1493
drug delivery systems (1448) 1448
antineoplastic agents (1400) 1400
dose-response relationship, drug (1398) 1398
survival rate (1398) 1398
antineoplastic agents, phytogenic - therapeutic use (1381) 1381
analysis (1355) 1355
paclitaxel - pharmacokinetics (1336) 1336
combined modality therapy (1335) 1335
deoxycytidine - analogs & derivatives (1306) 1306
antimitotic agents (1301) 1301
medicine & public health (1282) 1282
time factors (1282) 1282
cardiovascular system & cardiology (1273) 1273
retrospective studies (1271) 1271
antineoplastic agents - administration & dosage (1261) 1261
paclitaxel - analogs & derivatives (1252) 1252
drug therapy (1227) 1227
survival analysis (1227) 1227
taxoids (1202) 1202
prognosis (1189) 1189
follow-up studies (1187) 1187
cardiac & cardiovascular systems (1160) 1160
deoxycytidine - administration & dosage (1159) 1159
tumors (1120) 1120
carboplatin (1119) 1119
cancer therapies (1090) 1090
metastasis (1068) 1068
abridged index medicus (1056) 1056
ovarian neoplasms - pathology (1056) 1056
lung neoplasms - pathology (1054) 1054
doxorubicin - administration & dosage (1036) 1036
paclitaxel - chemistry (1035) 1035
obstetrics & gynecology (1012) 1012
antineoplastic agents, phytogenic - adverse effects (997) 997
drugs (983) 983
prospective studies (968) 968
chemotherapy, adjuvant (967) 967
docetaxel (951) 951
stents (946) 946
physical sciences (942) 942
health aspects (934) 934
nanoparticles (927) 927
infusions, intravenous (925) 925
antineoplastic agents - therapeutic use (923) 923
clinical trials (922) 922
drug-eluting stents (910) 910
antineoplastic agents, phytogenic - pharmacology (906) 906
chemistry (879) 879
dosage and administration (875) 875
mice, nude (873) 873
neoplasms - drug therapy (870) 870
cisplatin (853) 853
hematology, oncology and palliative medicine (851) 851
fluorouracil - administration & dosage (849) 849
apoptosis (842) 842
sirolimus - administration & dosage (842) 842
neoplasm metastasis (839) 839
adenocarcinoma - drug therapy (829) 829
apoptosis - drug effects (818) 818
surgery (792) 792
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18057) 18057
Japanese (834) 834
Chinese (211) 211
French (126) 126
German (80) 80
Spanish (43) 43
Russian (41) 41
Italian (36) 36
Hungarian (17) 17
Portuguese (17) 17
Korean (16) 16
Polish (13) 13
Czech (9) 9
Dutch (6) 6
Danish (4) 4
Turkish (3) 3
Hebrew (2) 2
Norwegian (2) 2
Croatian (1) 1
Finnish (1) 1
Lithuanian (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The lancet oncology, ISSN 1470-2045, 01/2015, Volume 16, Issue 1, pp. 87 - 97
Summary Background The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | Antineoplastic Agents - adverse effects | Adult | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Enzyme Inhibitors - adverse effects | Neoplasms, Cystic, Mucinous, and Serous - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Administration, Oral | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Neoplasms, Cystic, Mucinous, and Serous - enzymology | Treatment Outcome | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | BRCA1 Protein - genetics | Disease-Free Survival | Administration, Intravenous | Poly(ADP-ribose) Polymerases - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | BRCA2 Protein - genetics | Neoplasms, Cystic, Mucinous, and Serous - mortality | Phthalazines - adverse effects | Relapse | Chemotherapy | Hospitals | Gene mutations | Sugars | Diseases | Cancer | Monosaccharides | Ovarian cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2018, Volume 36, Issue 4, pp. 383 - 390
Journal Article
Journal Article
Journal of controlled release, ISSN 0168-3659, 01/2017, Volume 245, pp. 52 - 61
Due to their small size and unique properties, multifunctional nanoparticles arise as versatile delivery systems easily grafted with a vast array of functional... 
Targeting | Gold nanoparticles | Cancer therapy | Lung cancer | Colorectal cancer | Nanomedicine | Metal complexes | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Gold - administration & dosage | Drug Carriers - therapeutic use | Humans | Serum Albumin - administration & dosage | Drug Carriers - administration & dosage | Male | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Polyethylene Glycols - therapeutic use | Coordination Complexes - administration & dosage | Drug Carriers - chemistry | Nanoconjugates - therapeutic use | Paclitaxel - chemistry | Cobalt - therapeutic use | Fibroblasts | Paclitaxel - administration & dosage | Serum Albumin - chemistry | Gold - chemistry | Cell Survival - drug effects | Metal Nanoparticles - chemistry | Cells, Cultured | Metal Nanoparticles - therapeutic use | Cobalt - administration & dosage | Antineoplastic Agents - chemistry | Mice, SCID | Nanoconjugates - administration & dosage | Coordination Complexes - chemistry | Paclitaxel - therapeutic use | Polyethylene Glycols - administration & dosage | Neoplasms - drug therapy | Coordination Complexes - therapeutic use | Serum Albumin - therapeutic use | Animals | Metal Nanoparticles - administration & dosage | Tumor Burden - drug effects | Cell Line, Tumor | Gold - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice, Inbred NOD | Mice | Neoplasms - pathology | Cobalt - chemistry | Nanoconjugates - chemistry | Nanoparticles | Monoclonal antibodies | Chemotherapy | Epidermal growth factor | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1360 - 1372
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2016, Volume 388, Issue 10039, pp. 73 - 85
Summary Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence. Most patients with pancreatic cancer remain asymptomatic... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Leucovorin - administration & dosage | Endosonography | Pancreatic Neoplasms - diagnosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Tumor Suppressor Protein p53 - genetics | Carcinoembryonic Antigen - metabolism | Carcinoma, Pancreatic Ductal - genetics | Neoplasms, Cystic, Mucinous, and Serous - genetics | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Smad4 Protein - genetics | Carcinoma, Pancreatic Ductal - diagnosis | Camptothecin - administration & dosage | Paclitaxel - administration & dosage | Endoscopic Ultrasound-Guided Fine Needle Aspiration | Camptothecin - analogs & derivatives | Deoxycytidine - administration & dosage | Pancreatectomy | Albumins - administration & dosage | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - therapy | Genes, p16 | CA-19-9 Antigen - metabolism | Neoplasms, Cystic, Mucinous, and Serous - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Cystic, Mucinous, and Serous - diagnosis | Deoxycytidine - analogs & derivatives | Pancreatic Neoplasms - therapy | Medical colleges | Ultrasound imaging | Oncology, Experimental | Mortality | Japan | Pancreatitis | Adjuvant treatment | Leucovorin | Research | Pancreatic cancer | Diagnosis | Tumor proteins | Health aspects | Cancer | Pathology | Chemotherapy | Medical prognosis | Metastasis | Health risk assessment | Cancer therapies | Tumors | Index Medicus | Abridged Index Medicus
Journal Article